Page last updated: 2024-10-23

bunazosin and Chronic Primary Open Angle Glaucoma

bunazosin has been researched along with Chronic Primary Open Angle Glaucoma in 2 studies

bunazosin: structure

Research Excerpts

ExcerptRelevanceReference
"01% may provide an additional intraocular pressure reduction in patients already receiving latanoprost or timolol."5.11Efficacy of bunazosin hydrochloride 0.01% as adjunctive therapy of latanoprost or timolol. ( Kobayashi, H; Kobayashi, K; Okinami, S, 2004)
"To report a case of pigmentary glaucoma treated with medical therapy, laser treatment, and trabeculotomy."1.34[Case of pigmentary glaucoma treated with medical therapy, laser treatment, and trabeculotomy]. ( Higashide, T; Sugiyama, K; Wakabayashi, T, 2007)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kobayashi, H1
Kobayashi, K1
Okinami, S1
Wakabayashi, T1
Higashide, T1
Sugiyama, K1

Trials

1 trial available for bunazosin and Chronic Primary Open Angle Glaucoma

ArticleYear
Efficacy of bunazosin hydrochloride 0.01% as adjunctive therapy of latanoprost or timolol.
    Journal of glaucoma, 2004, Volume: 13, Issue:1

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Drug Administration Schedule; Drug

2004

Other Studies

1 other study available for bunazosin and Chronic Primary Open Angle Glaucoma

ArticleYear
[Case of pigmentary glaucoma treated with medical therapy, laser treatment, and trabeculotomy].
    Nippon Ganka Gakkai zasshi, 2007, Volume: 111, Issue:2

    Topics: Adrenergic alpha-Antagonists; Adult; Antihypertensive Agents; Argon; Glaucoma, Open-Angle; Humans; I

2007